Viatris Inc. (VTRS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$14.76
-0.27%
Mkt Cap $17.15B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $3.53B | $3.70B | +4.85% | $0.53 | $0.57 | +7.14% | — | — |
| Q4 2025 Nov 6, 2025 | $3.62B | $3.76B | +3.76% | $0.62 | $0.67 | +7.89% | — | — |
| Q3 2025 Aug 7, 2025 | $3.47B | $3.58B | +3.32% | $0.56 | $0.62 | +11.51% | — | — |
| Q2 2025 May 8, 2025 | $3.24B | $3.25B | +0.59% | $0.49 | $0.50 | +1.65% | — | — |
| Q1 2025 Feb 27, 2025 | $3.60B | $3.53B | -2.00% | $0.61 | $0.54 | -11.48% | — | — |
| Q4 2024 Nov 7, 2024 | $3.72B | $3.74B | +0.61% | $0.68 | $0.75 | +10.78% | — | — |
| Q3 2024 Aug 8, 2024 | $3.78B | $3.80B | +0.42% | $0.68 | $0.69 | +1.77% | — | — |
| Q2 2024 May 9, 2024 | $3.69B | $3.66B | -0.75% | $0.67 | $0.67 | -0.45% | — | — |
| Q1 2024 Feb 28, 2024 | $3.87B | $3.84B | -0.84% | $0.67 | $0.61 | -8.96% | — | — |
| Q4 2023 Nov 7, 2023 | $3.87B | $3.94B | +1.94% | $0.74 | $0.78 | +5.41% | — | — |
| Q3 2023 Aug 7, 2023 | $3.87B | $3.92B | +1.37% | $0.71 | $0.75 | +5.63% | — | — |
| Q2 2023 May 8, 2023 | $3.81B | $3.73B | -2.07% | $0.69 | $0.78 | +13.04% | — | — |
| Q1 2023 Feb 27, 2023 | $3.99B | $3.88B | -2.87% | $0.72 | $0.67 | -6.94% | — | — |
| Q4 2022 Nov 7, 2022 | $4.14B | $4.08B | -1.39% | $0.82 | $0.86 | +4.88% | — | — |
| Q3 2022 Aug 8, 2022 | $4.18B | $4.12B | -1.63% | $0.81 | $0.88 | +8.64% | — | — |
| Q2 2022 May 9, 2022 | $4.23B | $4.19B | -0.95% | $0.81 | $0.93 | +14.81% | — | — |
| Q1 2022 Feb 28, 2022 | $4.35B | $4.34B | -0.10% | $0.82 | $0.80 | -2.44% | — | — |
| Q4 2021 Nov 8, 2021 | $4.39B | $4.54B | +3.31% | $0.86 | $0.99 | +15.12% | — | — |
| Q3 2021 Aug 9, 2021 | $4.38B | $4.58B | +4.55% | $0.88 | $0.98 | +11.36% | — | — |
| Q2 2021 May 10, 2021 | $3.77B | $4.43B | +17.65% | $0.79 | $0.92 | +16.46% | — | — |